Description

Ti- Lira 30 mg functions by enhancing insulin response, reducing glucagon levels, delaying gastric emptying, and significantly suppressing appetite.

This dual-action mechanism leads to improved blood sugar regulation and dramatic reductions in body weight.

Tirzepatide is now widely used in medical weight management and body recomposition plans.

It provides both metabolic control and sustained appetite suppression, offering a reliable and well-tolerated option for long-term fat loss.

Benefits

*Improves insulin sensitivity and blood sugar control

* Promotes substantial weight loss by suppressing appetite

* ⁠Slows gastric emptying and prolongs satiety

* ⁠Reduces food cravings and overall caloric intake

* ⁠Supports cardiovascular and metabolic health

Side Effects

While generally well- tolerated, Ti-Lira 30 mg may cause temporary side effects such as:

* Nausea or gastrointestinal discomfort

* ⁠Constipation or diarrhea

* ⁠Headaches or fatigue

How to Administer

Ti- Lira 30 mg is injected subcutaneously once per week using the included pen and needles.
Steps:
1. Remove the cap and attach a new needle
2. Clean the injection site (abdomen or thigh)
3. ⁠Turn the dose dial to the correct number of clicks
4. ⁠Pinch the skin and insert the needle at a 90-degree angle
5. ⁠Press the injection button and hold for 5-10 seconds
6. ⁠Remove the pen and dispose of the needle safely
7. ⁠Recap and store the pen in the fridge Use a new needle for each injection. Rotate injection sites weekly.

Storage

* Store refrigerated at 2-8°C
* ⁠Do not freeze
* ⁠Keep capped when not in use
* ⁠Pen remains viable for up to 30 days after first use if refrigerated proper